Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Idelalisib

EU orphan designation number: EU/3/13/1186
Active ingredient: Idelalisib
Indication: Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)
Sponsor: Gilead Sciences International Ltd
Flowers Building, Granta Park, Abington, Cambridge CB21 6GT United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/105/13 (2013)5285 of 05/08/2013
21/10/2013 Centralised Orphan - Removal of orphan designation from Community Register